Adrenomedullin 2 (ADM2) is an endogenous bioactive peptide belonging to the calcitonin gene-related peptide family. Our previous studies showed that overexpression of ADM2 in mice reduced obesity and insulin resistance by increasing thermogenesis in brown adipose tissue. However, the effects of ADM2 in another type of thermogenic adipocyte, beige adipocytes, remain to be understood. The plasma ADM2 levels were inversely correlated with obesity in humans, and adipo-ADM2-transgenic (tg) mice displayed resistance to high-fat diet-induced obesity with increased energy expenditure. Beiging of subcutaneous white adipose tissues (WAT) was more noticeably induced in high-fat diet-fed transgenic mice with adipocyte-ADM2 overexpression (adipo-ADM2-tg mice) than in WT animals. ADM2 treatment in primary rat subcutaneous adipocytes induced beiging with up-regulation of UCP1 and beiging-related marker genes and increased mitochondrial uncoupling respiration, which was mainly mediated by activation of the calcitonin receptor-like receptor (CRLR)⅐receptor activitymodifying protein 1 (RAMP1) complex and PKA and p38 MAPK signaling pathways. Importantly, this adipocyte-autonomous beiging effect by ADM2 was translatable to human primary adipocytes. In addition, M2 macrophage activation also contributed to the beiging effects of ADM2 through catecholamine secretion. Therefore, our study reveals that ADM2 enhances subcutaneous WAT beiging via a direct effect by activating the CRLR⅐RAMP1-cAMP/PKA and p38 MAPK pathways in white adipocytes and via an indirect effect by stimulating alternative M2 polarization in macrophages. Through both mechanisms, beiging of WAT by ADM2 results in increased energy expenditure and reduced obesity, suggesting ADM2 as a novel anti-obesity target.An imbalance between energy intake and energy expenditure is the cause for the development of obesity, which is a high risk factor for type 2 diabetes and related metabolic disorders. Adaptive thermogenesis in adipose tissue is an important contributor to overall energy expenditure; thus, enhancing thermogenesis in adipose tissue is considered one of the promising therapeutic strategies to improve energy homeostasis (1).In contrast to white adipose tissue (WAT), 3 which stores energy as triglycerides, brown adipose tissue (BAT) dissipates energy as heat by uncoupling protein 1 (UCP1)-mediated uncoupling of the mitochondrial respiratory chain from ATP synthesis (2). Upon stimuli such as -3 adrenergic agonists or cold challenge, some adipocytes within WAT can exhibit brown-like features (3, 4) and have been identified as the third type of adipocytes, named "brite" (brown-in-white) or "beige" adipocytes (5). This biological process is referred to as WAT "browning" or "beiging" (3).Studies in both rodents and humans indicated that beiging of WAT increases the whole-body metabolic rate and improves energy homeostasis in obesity and type 2 diabetes (3, 6 -10). Enhancing WAT beiging alone was sufficient to alleviate obesity in mice (6), and emerging evidence also sugges...